Founded in 2009, JYMed is a pharmaceutical enterprise in China that integrates R&D,manufacturing,commercialization,and custom development and manufacturing of peptide products. The company has approximately 570 employees, with a core management team composed of professionals with pharmaceutical expertise and over 20 years of experience in the peptide industry. JYMed operates one research center and two major production facilities, achieving multi-ton scale production capacity in peptides, positioning it as an industry leader.